-
4D Molecular Therapeutics, Inc. (NASDAQ:FDMT) Receives Average Rating of "Buy" from Analysts
来源: Buzz FX / 23 9月 2024 05:01:10 America/New_York
4D Molecular Therapeutics, Inc. (NASDAQ:FDMT) Receives Average Rating of "Buy" from Analysts Written by MarketBeat September 23, 2024 Share Link copied to clipboard. Shares of 4D Molecular Therapeutics, Inc.
Read more...